Drug
Dcc 2618
Dcc 2618: highest development phase Phase 2, developed by Zai Lab. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Zai Lab
Trials
| Drug | Phase | Indication |
|---|---|---|
| DCC-2618 NCT04282980 | Phase 2 | Gastrointestinal Stromal Tumors |
Latest
No recent events.
Follow Dcc 2618 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.